Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Blood Transfusion Nursing Care Plan
Assessment
Patient identifiers: name, DOB, medical record number, blood type, transfusion order details (product, volume, rate, frequency)
Baseline vital signs: temperature, pulse, respiratory rate, blood pressure, oxygen saturation
Baseline lab values: hemoglobin/hematocrit, platelets, coagulation profile as indicated
Allergies and prior transfusion reactions history
Current medications (especially immunosuppressants, anticoagulants)
IV access: gauge, site, patency, compatibility with transfusion rate
Respiratory and cardiovascular status: auscultation, presence of edema, baseline perfusion
Skin integrity and neuro status
Religious/cultural beliefs or advance directives affecting transfusion
Patient/family knowledge, understanding, and consent documentation
Signs/symptoms during transfusion: fever, chills, urticaria, dyspnea, cough, chest/back/flank pain, hypotension, tachycardia, rigors, nausea, hematuria
Nursing Diagnoses
Risk for infection related to blood product contamination and invasive IV access
Risk for febrile non-hemolytic transfusion reaction related to recipient antibodies against donor leukocytes
Risk for allergic reaction related to plasma proteins in transfused product
Ineffective airway clearance related to transfusion-associated circulatory overload (TACO) or transfusion-related acute lung injury (TRALI)
Risk for fluid volume overload related to rapid or large-volume transfusion
Anxiety related to unfamiliar procedure and potential complications
Deficient knowledge regarding transfusion process and potential reactions
Goals/Expected Outcomes
Patient receives correct blood product without adverse reaction
Vital signs remain within acceptable limits for patient condition during and after transfusion
No signs of hemolytic or severe allergic reaction occur
Fluid status maintained without overload (no new pulmonary crackles, maintained oxygen saturation)
Patient and family demonstrate understanding of procedure, risks, and signs/symptoms to report
IV access remains patent and site remains intact without infiltration or infection
Nursing Interventions with Rationale
Verify orders and informed consent
Rationale: Ensures legal/ethical requirements are met and treatment is authorized.
Perform two-person patient and product identification check at bedside
Rationale: Prevents ABO incompatibility and transfusion errors; matches patient identifiers to blood product unit number, blood type, expiration date, and order.
Assess baseline vital signs and document immediately prior to initiation
Rationale: Provides comparison for early detection of transfusion reactions.
Ensure appropriate IV access (minimum 18–20 gauge for red blood cells; smaller gauge for platelets may be acceptable) and prime tubing with normal saline only
Rationale: Adequate lumen size prevents hemolysis and allows recommended flow rates; saline is compatible with blood products.
Administer blood product within recommended timeframes (start within 30 minutes of removal from blood bank; complete RBC transfusion within 4 hours)
Rationale: Minimizes bacterial growth and reduces risk of transfusion-associated complications.
Begin transfusion slowly for first 15 minutes (e.g., 2 mL/kg/h for pediatrics or 50 mL/hour adult), remain with patient for initial 15 minutes, then increase rate per order
Rationale: Most severe acute hemolytic and allergic reactions occur early; close observation allows immediate intervention.
Monitor vital signs per facility policy (commonly at baseline, 15 min after start, hourly during transfusion, and at completion) and more frequently if clinically indicated
Rationale: Detects early changes indicating reaction or fluid overload.
Observe for signs/symptoms of transfusion reaction and instruct patient/family to report itching, chills, back/chest pain, shortness of breath, or dark urine
Rationale: Early recognition enables prompt treatment and prevents complications.
If reaction suspected, stop transfusion immediately, clamp tubing, maintain IV line with normal saline using new tubing, notify provider and blood bank, send required samples (patient blood, tubing, urine) per protocol
Rationale: Stopping prevents further exposure; saline maintains IV access for medication; documentation and samples needed for workup.
Provide emergency interventions as indicated: oxygen, IV fluids, vasopressors, antihistamines, corticosteroids, epinephrine, diuretics, per provider orders and ACLS/acute care protocols
Rationale: Treats anaphylaxis, hypotension, bronchospasm, and fluid overload as appropriate.
Monitor fluid status: assess lung sounds, oxygen saturation, daily weights, intake/output; consider slower infusion rate,
Blood Transfusion Nursing Care Plan
Assessment
Patient identifiers: name, DOB, medical record number, blood type, transfusion order details (product, volume, rate, frequency)
Baseline vital signs: temperature, pulse, respiratory rate, blood pressure, oxygen saturation
Baseline lab values: hemoglobin/hematocrit, platelets, coagulation profile as indicated
Allergies and prior transfusion reactions history
Current medications (especially immunosuppressants, anticoagulants)
IV access: gauge, site, patency, compatibility with transfusion rate
Respiratory and cardiovascular status: auscultation, presence of edema, baseline perfusion
Skin integrity and neuro status
Religious/cultural beliefs or advance directives affecting transfusion
Patient/family knowledge, understanding, and consent documentation
Signs/symptoms during transfusion: fever, chills, urticaria, dyspnea, cough, chest/back/flank pain, hypotension, tachycardia, rigors, nausea, hematuria
Nursing Diagnoses
Risk for infection related to blood product contamination and invasive IV access
Risk for febrile non-hemolytic transfusion reaction related to recipient antibodies against donor leukocytes
Risk for allergic reaction related to plasma proteins in transfused product
Ineffective airway clearance related to transfusion-associated circulatory overload (TACO) or transfusion-related acute lung injury (TRALI)
Risk for fluid volume overload related to rapid or large-volume transfusion
Anxiety related to unfamiliar procedure and potential complications
Deficient knowledge regarding transfusion process and potential reactions
Goals/Expected Outcomes
Patient receives correct blood product without adverse reaction
Vital signs remain within acceptable limits for patient condition during and after transfusion
No signs of hemolytic or severe allergic reaction occur
Fluid status maintained without overload (no new pulmonary crackles, maintained oxygen saturation)
Patient and family demonstrate understanding of procedure, risks, and signs/symptoms to report
IV access remains patent and site remains intact without infiltration or infection
Nursing Interventions with Rationale
Verify orders and informed consent
Rationale: Ensures legal/ethical requirements are met and treatment is authorized.
Perform two-person patient and product identification check at bedside
Rationale: Prevents ABO incompatibility and transfusion errors; matches patient identifiers to blood product unit number, blood type, expiration date, and order.
Assess baseline vital signs and document immediately prior to initiation
Rationale: Provides comparison for early detection of transfusion reactions.
Ensure appropriate IV access (minimum 18–20 gauge for red blood cells; smaller gauge for platelets may be acceptable) and prime tubing with normal saline only
Rationale: Adequate lumen size prevents hemolysis and allows recommended flow rates; saline is compatible with blood products.
Administer blood product within recommended timeframes (start within 30 minutes of removal from blood bank; complete RBC transfusion within 4 hours)
Rationale: Minimizes bacterial growth and reduces risk of transfusion-associated complications.
Begin transfusion slowly for first 15 minutes (e.g., 2 mL/kg/h for pediatrics or 50 mL/hour adult), remain with patient for initial 15 minutes, then increase rate per order
Rationale: Most severe acute hemolytic and allergic reactions occur early; close observation allows immediate intervention.
Monitor vital signs per facility policy (commonly at baseline, 15 min after start, hourly during transfusion, and at completion) and more frequently if clinically indicated
Rationale: Detects early changes indicating reaction or fluid overload.
Observe for signs/symptoms of transfusion reaction and instruct patient/family to report itching, chills, back/chest pain, shortness of breath, or dark urine
Rationale: Early recognition enables prompt treatment and prevents complications.
If reaction suspected, stop transfusion immediately, clamp tubing, maintain IV line with normal saline using new tubing, notify provider and blood bank, send required samples (patient blood, tubing, urine) per protocol
Rationale: Stopping prevents further exposure; saline maintains IV access for medication; documentation and samples needed for workup.
Provide emergency interventions as indicated: oxygen, IV fluids, vasopressors, antihistamines, corticosteroids, epinephrine, diuretics, per provider orders and ACLS/acute care protocols
Rationale: Treats anaphylaxis, hypotension, bronchospasm, and fluid overload as appropriate.
Monitor fluid status: assess lung sounds, oxygen saturation, daily weights, intake/output; consider slower infusion rate,
